Ultomiris (ravulizumab)

pCPA File Number: 21780
Negotiation Status:
Active Negotiation
Indication(s):
Paroxysmal nocturnal hemoglobinuria (PNH)
Sponsor/Manufacturer:
Alexion Pharma Canada Corp.
CADTH Project Number:
SR0700
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable